198 results on '"Ahn, Youngkeun"'
Search Results
2. COVID-19 Vaccination–Related Pericarditis: A Korean Nationwide Study
3. Optimal timing of percutaneous coronary intervention for non-ST elevated myocardial infarction with congestive heart failure
4. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial
5. Identification of depression in patients with acute coronary syndrome using multiple serum biomarkers
6. Circular RNA circSMAD4 regulates cardiac fibrosis by targeting miR-671-5p and FGFR2 in cardiac fibroblasts
7. Renin-Angiotensin-Aldosterone System Inhibitions and Cardiovascular Outcomes in Acute Myocardial Infarction With Renal Impairment
8. Circular RNA circSmoc1-2 regulates vascular calcification by acting as a miR-874-3p sponge in vascular smooth muscle cells
9. Clinical Outcomes in Patients With Delayed Hospitalization for Non–ST-Segment Elevation Myocardial Infarction
10. Relationship of Serial High-Sensitivity C-Reactive Protein Changes to Long-term Clinical Outcomes in Stabilised Patients After Myocardial Infarction
11. Effects of Fixed-dose Combination of Low-intensity Rosuvastatin and Ezetimibe Versus Moderate-intensity Rosuvastatin Monotherapy on Lipid Profiles in Patients With Hypercholesterolemia: A Randomized, Double-blind, Multicenter, Phase III Study
12. Long-Term Outcomes of Patients With Late Presentation of ST-Segment Elevation Myocardial Infarction
13. miR-27a-3p Targets ATF3 to Reduce Calcium Deposition in Vascular Smooth Muscle Cells
14. Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy
15. Modifying effects of depression on the association between BDNF methylation and prognosis of acute coronary syndrome
16. Efficacy and Safety of Triple Therapy With Telmisartan, Amlodipine, and Rosuvastatin in Patients With Dyslipidemia and Hypertension: The Jeil Telmisartan, Amlodipine, and Rosuvastatin Randomized Clinical Trial
17. Outcomes After Predischarge Initiation of β-Blocker in Patients Hospitalized for Severe Decompensated Heart Failure Requiring Inotropic Therapy
18. Results of a 10-Year Experience in Korea Using Drug-Eluting Stents During Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the Korea Acute Myocardial Infarction Registry)
19. Effect of the Metabolic Syndrome on Outcomes in Patients Aged 50 Years With Acute Myocardial Infarction
20. Optimal Timing of Percutaneous Coronary Intervention in Patients With Non–ST-Segment Elevation Myocardial Infarction Complicated by Acute Decompensated Heart Failure (from the Korea Acute Myocardial Infarction Registry-National Institutes of Health [KAMIR-NIH])
21. Impact of Complete Revascularization on Six-Year Clinical Outcomes and Incidence of Acute Decompensated Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease
22. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl
23. Relationship between interleukin-1β and depressive disorder after acute coronary syndrome
24. Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk
25. Incidence, Implications, and Predictors of Stent Thrombosis in Acute Myocardial Infarction
26. Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non–Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)
27. Impact of Carvedilol Versus β1-Selective β Blockers (Bisoprolol, Metoprolol, and Nebivolol) in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
28. A Randomized, Multicenter, Double-blind, Placebo-controlled, 3 × 3 Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients With Essential Hypertension
29. The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test
30. Impact of Postdischarge Statin Withdrawal on Long-Term Outcomes in Patients With Acute Myocardial Infarction
31. Current Trend of Acute Myocardial Infarction in Korea (from the Korea Acute Myocardial Infarction Registry from 2006 to 2013)
32. Impact of Non–Chest Pain Complaint as a Presenting Symptom on Door-To-Balloon Time and Clinical Outcomes in Patients With Acute ST-Elevation Myocardial Infarction
33. Influence of Second- and Third-Degree Heart Block on 30-Day Outcome Following Acute Myocardial Infarction in the Drug-Eluting Stent Era
34. Gallic acid inhibits vascular calcification through the blockade of BMP2–Smad1/5/8 signaling pathway
35. Regulation of MMP/TIMP by HUVEC transplantation attenuates ventricular remodeling in response to myocardial infarction
36. Biomarkers for predicting depression after acute coronary syndrome
37. Intravascular Ultrasound Analysis of Plaque Characteristics and Postpercutaneous Coronary Intervention Catheterization Outcomes According to the Remodeling Pattern in Narrowed Saphenous Vein Grafts
38. Benefit of Percutaneous Coronary Intervention in Early Latecomers With Acute ST-Segment Elevation Myocardial Infarction
39. Comparison of Chronic Kidney Disease and Risk for Presenting With Painless Versus Nonpainless Acute Myocardial Infarction
40. Intravascular Ultrasound Findings That Are Predictive of No Reflow After Percutaneous Coronary Intervention for Saphenous Vein Graft Disease
41. Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 4
42. Benefit of Early Statin Therapy in Patients With Acute Myocardial Infarction Who Have Extremely Low Low-Density Lipoprotein Cholesterol
43. Hospital Discharge Risk Score System for the Assessment of Clinical Outcomes in Patients With Acute Myocardial Infarction (Korea Acute Myocardial Infarction Registry [KAMIR] Score)
44. Value of Early Risk Stratification Using Hemoglobin Level and Neutrophil-to-Lymphocyte Ratio in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
45. Management of Non–ST-Segment Elevation Acute Myocardial Infarction in Patients With Chronic Kidney Disease (from the Korea Acute Myocardial Infarction Registry)
46. Role of Intravascular Ultrasound in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
47. Impact of Baseline Plaque Components on Plaque Progression in Nonintervened Coronary Segments in Patients With Angina Pectoris on Rosuvastatin 10 mg/day
48. Low-Density Lipoprotein Cholesterol Level in Patients With Acute Myocardial Infarction Having Percutaneous Coronary Intervention (the Cholesterol Paradox)
49. Relation Between Aortic Knob Calcium Observed by Simple Chest X-Ray or Fluoroscopy and Plaque Components in Patients With Diabetes Mellitus
50. Effect of Renal Function on Ultrasonic Coronary Plaque Characteristics in Patients With Acute Myocardial Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.